<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03687528</url>
  </required_header>
  <id_info>
    <org_study_id>35RC17_8839_T.CAP</org_study_id>
    <nct_id>NCT03687528</nct_id>
  </id_info>
  <brief_title>Platelet Inhibitor Treated Patients With Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ?</brief_title>
  <acronym>TCAP</acronym>
  <official_title>Platelet Inhibitor Treated Patients With Head Injury Trauma Without Any Clinical Symptoms of Cerebral Haemorrhage (NICE Criteria) : is the CT-scan Mandatory ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      At the emergencies rooms, patients with head trauma meeting one of the NICE criteria, which&#xD;
      include antiplatelet inhibitors treatment, are considered as patients with a risk of cerebral&#xD;
      haemorrage and are taken systematically for a CT-scanner.&#xD;
&#xD;
      However, there are more and more antiplatelet inhibitor's patient with minor head injury&#xD;
      traumas seen at the emergencies room and the efficiency of this NICE criteria is&#xD;
      controversial on litterature.&#xD;
&#xD;
      This study aims to determine that the absence of no other NICE criteria than antiplatelet&#xD;
      inhibitors is a sufficient condition to eliminate a cerebral haemorrhage for patients with&#xD;
      head injury traumas, and conversely, that antiplatelet inhibitors treatment would not be by&#xD;
      itself an indication for a CT-scanner.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Head injuries are a frequent reason for emergency services, and according to studies, they&#xD;
      represent between 5% and 10% of patients treated in emergencies. Among them, 90% are minor&#xD;
      head injury traumas. NICE criteria has been defined to establish patients who need a&#xD;
      CT-scanner because of a risk of cerebral haemorrhage.&#xD;
&#xD;
      NICE criteria include several conditions including taking antiplatelet inhibitors. However,&#xD;
      the real risk of cerebral haemorrhage for theses cases is controversial in litterature. In&#xD;
      parallel, more and more patients undergoing antiplatelet inhibitor's treatment are seen in&#xD;
      emergencies after a head injury trauma.&#xD;
&#xD;
      In routine protocol at the emergency rooms, these patients are seen for a clinical exam and&#xD;
      next submitted to a CT-scanner. If the clinician can't detect a cerebral haemorrage, the&#xD;
      patient will return at home.&#xD;
&#xD;
      This study aims to determine that the absence of no other NICE criteria than antiplatelet&#xD;
      inhibitors treatment is a sufficient condition to eliminate a cerebral haemorrhage for&#xD;
      patients with head injury traumas, and conversely, that antiplatelet inhibitors treatment&#xD;
      would not be by itself an indication for a CT-scanner.&#xD;
&#xD;
      This is a diagnostic, case-only, prospective, multicenter study with a blinded primary&#xD;
      outcome measure assessment.&#xD;
&#xD;
      As described in routine protocol, in this study antiplatelet inhibitor's patients with head&#xD;
      injury trauma will be seen for a clinical exam and next submitted to a CT-scanner. After a&#xD;
      month, patient will be called by the clinical center to ask about morbidity and mortality.&#xD;
      Especially, clinicans will report on the emergence of a cerebral haemorrhage during this&#xD;
      month.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">December 28, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Existence of a cerebral haemorrhage at the CT-scanner.</measure>
    <time_frame>1 day</time_frame>
    <description>Cerebral haemorrhage seen at the CT-scanner.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurosurgeries' rate after one month</measure>
    <time_frame>1 month</time_frame>
    <description>Neurosurgeries' rate after one month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Existence of a cerebral haemorrhage associated to death</measure>
    <time_frame>1 month</time_frame>
    <description>Existence of a cerebral haemorrhage associated to death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Existence of a cerebral haemorrhage associated to neurosurgery</measure>
    <time_frame>1 month</time_frame>
    <description>Existence of a cerebral haemorrhage associated to neurosurgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Existence of a cerebral haemorrhage associated to hospitalization with more than 24h of intubation</measure>
    <time_frame>1 month</time_frame>
    <description>Existence of a cerebral haemorrhage associated to hospitalization with more than 24h of intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Existence of a cerebral haemorrhage associated to more than 2 nights at hospital</measure>
    <time_frame>1 month</time_frame>
    <description>Existence of a cerebral haemorrhage associated to more than 2 nights at hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death rate after one month</measure>
    <time_frame>1 month</time_frame>
    <description>Death rate after one month</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3200</enrollment>
  <condition>Head Injury Trauma</condition>
  <condition>Emergencies</condition>
  <arm_group>
    <arm_group_label>Patient with minor head injury trauma</arm_group_label>
    <description>The emergency protocol for antiplatelet inhibitors treated patient with head injury trauma and meeting others NICE criteria involves a clinical exam followed by a CT-scanner.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>CT-scanner</intervention_name>
    <description>After a clinical exam, patient have a CT-scanner to check any cerebral haemorrhage.</description>
    <arm_group_label>Patient with minor head injury trauma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Major patients undergoing antiplatelet inhibitors treatment which are reported at the&#xD;
        clinical exam as having a head injury trauma.&#xD;
&#xD;
        These patients don't meet another NICE criteria :&#xD;
&#xD;
          -  neurological focal deficit&#xD;
&#xD;
          -  amnesia for more than 30 min&#xD;
&#xD;
          -  glasgow score less than 15 after 2 hours&#xD;
&#xD;
          -  loss of consciousness associated with either a high velocity or an age &gt; 65 years old&#xD;
&#xD;
          -  suspicion of a cranial open fracture&#xD;
&#xD;
          -  fracture on cranial basis&#xD;
&#xD;
          -  more than 1 vomit&#xD;
&#xD;
          -  post-traumatic convulsion&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 18 years old&#xD;
&#xD;
          -  Patient with a head injury trauma, described by the patient or seen at the clinical&#xD;
             exam&#xD;
&#xD;
          -  Glasgow score between 13 and 15 at the clinical exam&#xD;
&#xD;
          -  Current treatment with antiplatelet inhibitors&#xD;
&#xD;
          -  Informed non opposition form signed&#xD;
&#xD;
        Exclusion Criteria :&#xD;
&#xD;
        - Absence of CT-scanner&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jérémie BONENFANT, Md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jérémie BONENFANT, Md</last_name>
    <phone>+33 2 99 28 43 21</phone>
    <email>jeremie.bonenfant@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Laure GERVAIS</last_name>
    <phone>0299284312</phone>
    <email>marie-laure.gervais@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre-Marie ROY, Pr</last_name>
      <phone>+33241356650</phone>
      <email>pmroy@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Chartres</name>
      <address>
        <city>Chartres</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Baptiste DESHAYES, Md</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Le Mans</name>
      <address>
        <city>Le Mans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thibault SCHOTTE, Md</last_name>
      <phone>+33243434343</phone>
      <email>tschotte@ch-lemans.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Bretagne Sud, Lorient</name>
      <address>
        <city>Lorient</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie DANIEL, Md</last_name>
      <phone>+33297069090</phone>
    </contact>
    <investigator>
      <last_name>Thomas LE NORMAND</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Camille LARUE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel MONTASSIER, Md</last_name>
      <phone>+33240083934</phone>
      <email>emmanuel.montassier@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier MIMOZ, Pr</last_name>
      <phone>+33549444600</phone>
      <email>o.mimoz@chu-poitiers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Bretagne Sud - Quimperlé</name>
      <address>
        <city>Quimperlé</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CHU de Rennes</last_name>
      <phone>299284312</phone>
      <email>marie-laure.gervais@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Jérémie BONENFANT, Md</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacques BOUGET, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Saint Brieuc</name>
      <address>
        <city>Saint-Brieuc</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian BRICE, Md</last_name>
      <phone>+33296017489</phone>
      <email>christian.brice@ch-stbrieuc.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH de Saint Malo</name>
      <address>
        <city>Saint-Malo</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabrina PERNET, Md</last_name>
      <phone>+33299212121</phone>
      <email>s.pernet@ch-stmalo.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>September 26, 2018</study_first_submitted>
  <study_first_submitted_qc>September 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2018</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>emergencies</keyword>
  <keyword>platelet inhibitors</keyword>
  <keyword>minor head injury trauma</keyword>
  <keyword>CT-scan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Craniocerebral Trauma</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

